Regulation of neuronal nicotinic receptor traffic and expression

Brain Research Reviews

Volumn 55, Issue 1, 2007, Pages 134-143

  Gaimarri, Annalisa ^a   Moretti, Milena ^a   Riganti, Loredana ^a   Zanardi, Alessio ^b   Clementi, Francesco ^a   Gotti, Cecilia ^a  

^a CNR   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

1,2 bis N cytisinylethane (CC4); Neuronal nicotinic receptor; Nicotine; Subtypes; Up regulation

Indexed keywords

1,2 BIS N CYTISINYLETHANE; CATION CHANNEL; CC 4; CHOLINERGIC RECEPTOR STIMULATING AGENT; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; PROTEIN SUBUNIT; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; BIOPHYSICS; BRAIN; CELL MIGRATION; CENTRAL NERVOUS SYSTEM; DEGENERATIVE DISEASE; DRUG MECHANISM; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR DYNAMICS; NERVE CELL; NEUROMODULATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; REVIEW; STOICHIOMETRY; UPREGULATION;

ANIMALS; BRAIN; GENE EXPRESSION REGULATION; NEURONS; NICOTINIC ANTAGONISTS; PROTEIN TRANSPORT; RECEPTORS, NICOTINIC;

EID: 34548407296     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresrev.2007.02.005     Document Type: Review

References (72)

1. Boido C.C., Tasso B., Boido V., and Sparatore F. Cytisine derivatives as ligands for neuronal nicotine receptors and with various pharmacological activities. Farmaco 58 (2003) 265-277
2. Broadbent S., Groot-Kormelink P.J., Krashia P.A., Harkness P.C., Millar N.S., Beato M., and Sivilotti L.G. Incorporation of the beta3 subunit has a dominant-negative effect on the function of recombinant central-type neuronal nicotinic receptors. Mol. Pharmacol. 70 (2006) 1350-1357
3. Buisson B., and Bertrand D. Chronic exposure to nicotine upregulates the human (alpha)4(beta)2 nicotinic acetylcholine receptor function. J. Neurosci. 21 (2001) 1819-1829
4. Canu Boido C., and Sparatore F. Synthesis and preliminary pharmacological evaluation of some cytisine derivatives. Farmaco 54 (1999) 438-451
5. Carbonnelle E., Sparatore F., Canu-Boido C., Salvagno C., Baldani-Guerra B., Terstappen G., Zwart R., Vijverberg H., Clementi F., and Gotti C. Nitrogen substitution modifies the activity of cytisine on neuronal nicotinic receptor subtypes. Eur. J. Pharmacol. 471 (2003) 85-96
6. Celie P.H., van Rossum-Fikkert S.E., van Dijk W.J., Brejc K., Smit A.B., and Sixma T.K. Nicotine and carbamylcholine binding to nicotinic acetylcholine receptors as studied in AChBP crystal structures. Neuron 41 (2004) 907-914
7. Champtiaux N., and Changeux J.P. Knock-out and knock-in mice to investigate the role of nicotinic receptors in the central nervous system. Curr. Drug Targets. CNS Neurol. Disord. 1 (2002) 319-330
8. Champtiaux N., Gotti C., Cordero-Erausquin M., David D.J., Przybylski C., Lena C., Clementi F., Moretti M., Rossi F.M., Le Novere N., McIntosh J.M., Gardier A.M., and Changeux J.P. Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice. J. Neurosci. 23 (2003) 7820-7829
9. Changeux J.P., and Edelstein S.J. Allosteric receptors after 30 years. Neuron 21 (1998) 959-980
10. Chavez-Noriega L.E., Crona J.H., Washburn M.S., Urrutia A., Elliott K.J., and Johnson E.C. Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors h alpha 2 beta 2, h alpha 2 beta 4, h alpha 3 beta 2, h alpha 3 beta 4, h alpha 4 beta 2, h alpha 4 beta 4 and h alpha 7 expressed in Xenopus oocytes. J. Pharmacol. Exp. Ther. 280 (1997) 346-356
11. Corringer P.J., Le Novere N., and Changeux J.P. Nicotinic receptors at the amino acid level. Annu. Rev. Pharmacol. Toxicol. 40 (2000) 431-458
12. Dajas-Bailador F., and Wonnacott S. Nicotinic acetylcholine receptors and the regulation of neuronal signalling. Trends Pharmacol. Sci. 25 (2004) 317-324
13. Darsow T., Booker T.K., Pina-Crespo J.C., and Heinemann S.F. Exocytic trafficking is required for nicotine-induced up-regulation of alpha 4 beta 2 nicotinic acetylcholine receptors. J. Biol. Chem. 280 (2005) 18311-18320
14. Drago J., McColl C.D., Horne M.K., Finkelstein D.I., and Ross S.A. Neuronal nicotinic receptors: insights gained from gene knockout and knockin mutant mice. Cell. Mol. Life Sci. 60 (2003) 1267-1280
15. Ficklin M.B., Zhao S., and Feng G. Ubiquilin-1 regulates nicotine-induced up-regulation of neuronal nicotinic acetylcholine receptors. J. Biol. Chem. 280 (2005) 34088-34095
16. 2+ permeability of nicotinic acetylcholine receptors. Cell Calcium 35 (2004) 1-8
17. Gentry C.L., and Lukas R.J. Regulation of nicotinic acetylcholine receptor numbers and function by chronic nicotine exposure. Curr. Drug Targets. CNS Neurol. Disord. 1 (2002) 359-385
18. Gotti C., and Clementi F. Neuronal nicotinic receptors: from structure to pathology. Prog. Neurobiol. 74 (2004) 363-396
19. Gotti C., Moretti M., Clementi F., Riganti L., McIntosh J.M., Collins A.C., Marks M.J., and Whiteaker P. Expression of nigrostriatal alpha 6-containing nicotinic acetylcholine receptors is selectively reduced, but not eliminated, by beta 3 subunit gene deletion. Mol. Pharmacol. 67 (2005) 2007-2015
20. Gotti C., Zoli M., and Clementi F. Brain nicotinic acetylcholine receptors: native subtypes and their relevance. Trends Pharmacol. Sci. 27 (2006) 482-491
21. Green W.N., and Millar N.S. Ion-channel assembly. Trends Neurosci. 18 (1995) 280-287
22. Grilli M., Parodi M., Raiteri M., and Marchi M. Chronic nicotine differentially affects the function of nicotinic receptor subtypes regulating neurotransmitter release. J. Neurochem. 93 (2005) 1353-1360
23. Halevi S., Yassin L., Eshel M., Sala F., Sala S., Criado M., and Treinin M. Conservation within the RIC-3 gene family. Effectors of mammalian nicotinic acetylcholine receptor expression. J. Biol. Chem. 278 (2003) 34411-34417
24. Hansen S.B., Sulzenbacher G., Huxford T., Marchot P., Taylor P., and Bourne Y. Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations. EMBO J. 24 (2005) 3635-3646
25. Harkness P.C., and Millar N.S. Changes in conformation and subcellular distribution of alpha4beta2 nicotinic acetylcholine receptors revealed by chronic nicotine treatment and expression of subunit chimeras. J. Neurosci. 22 (2002) 10172-10181
26. Hogg R.C., Raggenbass M., and Bertrand D. Nicotinic acetylcholine receptors: from structure to brain function. Rev. Physiol., Biochem. Pharmacol. 147 (2003) 1-46
27. Jeanclos E.M., Lin L., Treuil M.W., Rao J., DeCoster M.A., and Anand R. The chaperone protein 14-3-3eta interacts with the nicotinic acetylcholine receptor alpha 4 subunit. Evidence for a dynamic role in subunit stabilization. J. Biol. Chem. 276 (2001) 28281-28290
28. Jensen A.A., Frolund B., Liljefors T., and Krogsgaard-Larsen P. Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations. J. Med. Chem. 48 (2005) 4705-4745
29. Khiroug S.S., Harkness P.C., Lamb P.W., Sudweeks S.N., Khiroug L., Millar N.S., and Yakel J.L. Rat nicotinic ACh receptor alpha7 and beta2 subunits co-assemble to form functional heteromeric nicotinic receptor channels. J. Physiol. 540 (2002) 425-434
30. Kittler J.T., and Moss S.J. Neurotransmitter receptor trafficking and the regulation of synaptic strength. Traffic 2 (2001) 437-448
31. Kuryatov A., Luo J., Cooper J., and Lindstrom J. Nicotine acts as a pharmacological chaperone to up-regulate human alpha4beta2 acetylcholine receptors. Mol. Pharmacol. 68 (2005) 1839-1851
32. Lai A., Parameswaran N., Khwaja M., Whiteaker P., Lindstrom J.M., Fan H., McIntosh J.M., Grady S.R., and Quik M. Long-term nicotine treatment decreases striatal alpha 6* nicotinic acetylcholine receptor sites and function in mice. Mol. Pharmacol. 67 (2005) 1639-1647
33. Lansdell S.J., Gee V.J., Harkness P.C., Doward A.I., Baker E.R., Gibb A.J., and Millar N.S. RIC-3 enhances functional expression of multiple nicotinic acetylcholine receptor subtypes in mammalian cells. Mol. Pharmacol. 68 (2005) 1431-1438
34. Laviolette S.R., and van der Kooy D. The neurobiology of nicotine addiction: bridging the gap from molecules to behaviour. Nat. Rev., Neurosci. 5 (2004) 55-65
35. Le Novere N., Corringer P.J., and Changeux J.P. The diversity of subunit composition in nAChRs: evolutionary origins, physiologic and pharmacologic consequences. J. Neurobiol. 53 (2002) 447-456
36. Lin L., Jeanclos E.M., Treuil M., Braunewell K.H., Gundelfinger E.D., and Anand R. The calcium sensor protein visinin-like protein-1 modulates the surface expression and agonist sensitivity of the alpha 4beta 2 nicotinic acetylcholine receptor. J. Biol. Chem. 277 (2002) 41872-41878
37. Lindstrom J. The structures of neuronal nicotinic receptors. In: Clementi F., Fornasari D., and Gotti C. (Eds). Handbook of Experimental Pharmacology, Vol. Neuronal Nicotinic Receptors (2000), Springer, Berlin 101-162
38. Marks M.J., Pauly J.R., Gross S.D., Deneris E.S., Hermans-Borgmeyer I., Heinemann S.F., and Collins A.C. Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. J. Neurosci. 12 (1992) 2765-2784
39. Marks M.J., Farnham D.A., Grady S.R., and Collins A.C. Nicotinic receptor function determined by stimulation of rubidium efflux from mouse brain synaptosomes. J. Pharmacol. Exp. Ther. 264 (1993) 542-552
40. Marks M.J., Whiteaker P., Calcaterra J., Stitzel J.A., Bullock A.E., Grady S.R., Picciotto M.R., Changeux J.P., and Collins A.C. Two pharmacologically distinct components of nicotinic receptor-mediated rubidium efflux in mouse brain require the beta2 subunit. J. Pharmacol. Exp. Ther. 289 (1999) 1090-1103
41. Marks M.J., Rowell P.P., Cao J.Z., Grady S.R., McCallum S.E., and Collins A.C. Subsets of acetylcholine-stimulated 86Rb+ efflux and [125I]-epibatidine binding sites in C57BL/6 mouse brain are differentially affected by chronic nicotine treatment. Neuropharmacology 46 (2004) 1141-1157
42. Moretti M., Vailati S., Zoli M., Lippi G., Riganti L., Longhi R., Viegi A., Clementi F., and Gotti C. Nicotinic acetylcholine receptor subtypes expression during rat retina development and their regulation by visual experience. Mol. Pharmacol. 66 (2004) 85-96
43. Moroni M., Zwart R., Sher E., Cassels B.K., and Bermudez I. alpha4beta2 nicotinic receptors with high and low acetylcholine sensitivity: pharmacology, stoichiometry, and sensitivity to long-term exposure to nicotine. Mol. Pharmacol. 70 (2006) 755-768
44. Mugnaini M., Garzotti M., Sartori I., Pilla M., Repeto P., Heidbreder C.A., and Tessari M. Selective down-regulation of [(125)I]Y0-alpha-conotoxin MII binding in rat mesostriatal dopamine pathway following continuous infusion of nicotine. Neuroscience 137 (2006) 565-572
45. Nashmi R., Dickinson M.E., McKinney S., Jareb M., Labarca C., Fraser S.E., and Lester H.A. Assembly of alpha4beta2 nicotinic acetylcholine receptors assessed with functional fluorescently labeled subunits: effects of localization, trafficking, and nicotine-induced upregulation in clonal mammalian cells and in cultured midbrain neurons. J. Neurosci. 23 (2003) 11554-11567
46. Nelson M.E., Kuryatov A., Choi C.H., Zhou Y., and Lindstrom J. Alternate stoichiometries of alpha4beta2 nicotinic acetylcholine receptors. Mol. Pharmacol. 63 (2003) 332-341
47. Nguyen H.N., Rasmussen B.A., and Perry D.C. Binding and functional activity of nicotinic cholinergic receptors in selected rat brain regions are increased following long-term but not short-term nicotine treatment. J. Neurochem. 90 (2004) 40-49
48. Palma E., Maggi L., Barabino B., Eusebi F., and Ballivet M. Nicotinic acetylcholine receptors assembled from the alpha7 and beta3 subunits. J. Biol. Chem. 274 (1999) 18335-18340
49. Parker S.L., Fu Y., McAllen K., Luo J., McIntosh J.M., Lindstrom J.M., and Sharp B.M. Up-regulation of brain nicotinic acetylcholine receptors in the rat during long-term self-administration of nicotine: disproportionate increase of the alpha6 subunit. Mol. Pharmacol. 65 (2004) 611-622
50. Paton W.D., and Zaimis E.J. The pharmacological actions of polymethylene bistrimethyl-ammonium salts. Br. J. Pharmacol. Chemother. 4 (1949) 381-400
51. Peng X., Gerzanich V., Anand R., Wang F., and Lindstrom J. Chronic nicotine treatment up-regulates alpha3 and alpha7 acetylcholine receptor subtypes expressed by the human neuroblastoma cell line SH-SY5Y. Mol. Pharmacol. 51 (1997) 776-784
52. Perry D.C., Davila-Garcia M.I., Stockmeier C.A., and Kellar K.J. Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies. J. Pharmacol. Exp. Ther. 289 (1999) 1545-1552
53. Picciotto M.R. Nicotine as a modulator of behavior: beyond the inverted U. Trends Pharmacol. Sci. 24 (2003) 493-499
54. Picciotto M.R., Caldarone B.J., King S.L., and Zachariou V. Nicotinic receptors in the brain. Links between molecular biology and behavior. Neuropsychopharmacology 22 (2000) 451-465
55. Picciotto M.R., Caldarone B.J., Brunzell D.H., Zachariou V., Stevens T.R., and King S.L. Neuronal nicotinic acetylcholine receptor subunit knockout mice: physiological and behavioral phenotypes and possible clinical implications. Pharmacol. Ther. 92 (2001) 89-108
56. Pidoplichko V.I., DeBiasi M., Williams J.T., and Dani J.A. Nicotine activates and desensitizes midbrain dopamine neurons. Nature 390 (1997) 401-404
57. Quik M., Vailati S., Bordia T., Kulak J.M., Fan H., McIntosh J.M., Clementi F., and Gotti C. Subunit composition of nicotinic receptors in monkey striatum: effect of treatments with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine or l-DOPA. Mol. Pharmacol. 67 (2005) 32-41
58. Ren X.Q., Cheng S.B., Treuil M.W., Mukherjee J., Rao J., Braunewell K.H., Lindstrom J.M., and Anand R. Structural determinants of alpha4beta2 nicotinic acetylcholine receptor trafficking. J. Neurosci. 25 (2005) 6676-6686
59. Riganti L., Matteoni C., Di Angelantonio S., Nistri A., Gaimarri A., Sparatore F., Canu-Boido C., Clementi F., and Gotti C. Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells. Br. J. Pharmacol. 146 (2005) 1096-1109
60. Rowell P.P., and Wonnacott S. Evidence for functional activity of up-regulated nicotine binding sites in rat striatal synaptosomes. J. Neurochem. 55 (1990) 2105-2110
61. Sallette J., Bohler S., Benoit P., Soudant M., Pons S., Le Novere N., Changeux J.P., and Corringer P.J. An extracellular protein microdomain controls up-regulation of neuronal nicotinic acetylcholine receptors by nicotine. J. Biol. Chem. 279 (2004) 18767-18775
62. Sallette J., Pons S., Devillers-Thiery A., Soudant M., Prado de Carvalho L., Changeux J.P., and Corringer P.J. Nicotine upregulates its own receptors through enhanced intracellular maturation. Neuron 46 (2005) 595-607
63. Sine S.M., and Engel A.G. Recent advances in Cys-loop receptor structure and function. Nature 440 (2006) 448-455
64. Tumkosit P., Kuryatov A., Luo J., and Lindstrom J. Beta3 subunits promote expression and nicotine-induced up-regulation of human nicotinic alpha6* nicotinic acetylcholine receptors expressed in transfected cell lines. Mol. Pharmacol. 70 (2006) 1358-1368
65. Vallejo Y.F., Buisson B., Bertrand D., and Green W.N. Chronic nicotine exposure upregulates nicotinic receptors by a novel mechanism. J. Neurosci. 25 (2005) 5563-5572
66. Villarroya M., Gandia L., Lopez M.G., Garcia A.G., Cueto S., Garcia-Navio J.L., and Alvarez-Builla J. Synthesis and pharmacology of alkanediguanidinium compounds that block the neuronal nicotinic acetylcholine receptor. Bioorg. Med. Chem. 4 (1996) 1177-1183
67. Vincler M., Wittenauer S., Parker R., Ellison M., Olivera B.M., and McIntosh J.M. Molecular mechanism for analgesia involving specific antagonism of alpha9alpha10 nicotinic acetylcholine receptors. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 17880-17884
68. Wang F., Nelson M.E., Kuryatov A., Olale F., Cooper J., Keyser K., and Lindstrom J. Chronic nicotine treatment up-regulates human alpha3 beta2 but not alpha3 beta4 acetylcholine receptors stably transfected in human embryonic kidney cells. J. Biol. Chem. 273 (1998) 28721-28732
69. Williams B.M., Temburni M.K., Levey M.S., Bertrand S., Bertrand D., and Jacob M.H. The long internal loop of the alpha 3 subunit targets nAChRs to subdomains within individual synapses on neurons in vivo. Nat. Neurosci. 1 (1998) 557-562
70. Williams M.E., Burton B., Urrutia A., Shcherbatko A., Chavez-Noriega L.E., Cohen C.J., and Aiyar J. Ric-3 promotes functional expression of the nicotinic acetylcholine receptor alpha7 subunit in mammalian cells. J. Biol. Chem. 280 (2005) 1257-1263
71. Xu J., Zhu Y., and Heinemann S.F. Identification of sequence motifs that target neuronal nicotinic receptors to dendrites and axons. J. Neurosci. 26 (2006) 9780-9793
72. Yu Z.J., and Wecker L. Chronic nicotine administration differentially affects neurotransmitter release from rat striatal slices. J. Neurochem. 63 (1994) 186-194